Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CDKN2A |
Variant | V96Afs*22 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | CDKN2A V96Afs*22 indicates a shift in the reading frame starting at amino acid 96 and terminating 22 residues downstream causing a premature truncation of the 156 amino acid Cdkn2a protein (UniProt.org). V96Afs*22 has not been characterized, however, due to the effects of other truncation mutations downstream of V96 (PMID: 9053859, PMID: 8668202), is predicted to lead to a loss of Cdkn2a protein function. |
Associated Drug Resistance | |
Category Variants Paths |
CDKN2A mutant CDKN2A inact mut CDKN2A V96Afs*22 |
Transcript | NM_000077.5 |
gDNA | chr9:g.(21971005_21971073) |
cDNA | c.(286_354) |
Protein | p.V96Afs*22 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000077.4 | chr9:g.(21971005_21971073) | c.(286_354) | p.V96Afs*22 | RefSeq | GRCh38/hg38 |
NM_001195132.1 | chr9:g.(21971005_21971073) | c.(286_354) | p.V96Afs*22 | RefSeq | GRCh38/hg38 |
NM_058197.5 | chr9:g.(21974542_21974830) | c.(286_354) | p.V96Afs*22 | RefSeq | GRCh38/hg38 |
XM_011517675.2 | chr9:g.(21971005_21971073) | c.(286_354) | p.V96Afs*22 | RefSeq | GRCh38/hg38 |
XM_011517676.2 | chr9:g.(21971005_21971073) | c.(286_354) | p.V96Afs*22 | RefSeq | GRCh38/hg38 |
NM_000077.5 | chr9:g.(21971005_21971073) | c.(286_354) | p.V96Afs*22 | RefSeq | GRCh38/hg38 |
NM_058197.4 | chr9:g.(21974542_21974830) | c.(286_354) | p.V96Afs*22 | RefSeq | GRCh38/hg38 |
XM_011517676.3 | chr9:g.(21971005_21971073) | c.(286_354) | p.V96Afs*22 | RefSeq | GRCh38/hg38 |
XM_011517675.3 | chr9:g.(21971005_21971073) | c.(286_354) | p.V96Afs*22 | RefSeq | GRCh38/hg38 |
NM_001195132.2 | chr9:g.(21971005_21971073) | c.(286_354) | p.V96Afs*22 | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|